Novavax Developing Vaccine #covid19 #vaccine

 Novavax Inc said on Friday it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks.

The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system. The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.

https://torontosun.com/news/world/novavax-developing-vaccine-that-targets-new-covid-19-variant?utm_term=Autofeed&utm_medium=Social&utm_source=Twitter#Echobox=1637976091